Lacosamide is a functionalized amino acid (with similarity to d-serine) that is approved by the US FDA and EMEA as an adjunctive therapy for partial-onset seizures. Lacosamide is believed to exert ...
The disorders are often associated with seizures and intellectual disability and currently there are no available treatments. A new Yale study, however, has identified a molecular mechanism that ...